“…Caco-2 cells were seeded in a 75 cm 2 flask at a density of 1 × 10 4 cells/cm 2 ; 24 h later, they were exposed to the drug panel for 48 or 72 h. Then, the cells were collected and processed as previously described [ 59 , 61 ]. Finally, 50 µL of every sample was incubated with 5 µL anti-active caspase-3 (BD Pharmigen, San Diego, CA, USA, Clone C92-605) and 5 µL p53 antibody (Miltenyi, Auburn, CA, USA, Clone REA609).…”